COMMUNIQUÉS West-GlobeNewswire

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic [...]
Acquisition of Own Shares
01/09/2026
Mechelen, Belgium; 01 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Adam Ferrari Health Science Scholarship Names Eshaan Verma 2026 Recipient
01/09/2026
IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Ferrari Foundation has named Eshaan Verma as the recipient of the 2026 Adam Ferrari Health Science Scholarship , a $20,000 award supporting students pursuing health [...]
Earth Science Tech, Inc. Announces 2026 Annual Shareholder Meeting Results
01/09/2026
MIAMI, FL, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) ("Earth Science Tech" or the "Company") today announced the voting results from its first Annual Meeting of Stockholders, held virtually [...]
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients [...]
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
01/09/2026
Company anticipates response from FDA by mid-September 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease. SAN DIEGO, Sept. 01, 2026 [...]
STERIS to Present at the Morgan Stanley Healthcare Conference
01/09/2026
Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, [...]
Cellectis Announces Participation in Upcoming Investor Conferences
01/09/2026
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]
Cellectis annonce sa participation à plusieurs conférences investisseurs
01/09/2026
NEW YORK, 01 sept. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour développer des [...]
Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September
01/09/2026
TEL AVIV, Israel, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at three upcoming investor [...]
Tarsus to Participate in Upcoming Investor Conferences
01/09/2026
IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor conferences: Wells Fargo 21 st Annual [...]
Braveheart Bio to Participate in Cantor Global Healthcare Conference
01/09/2026
SAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other [...]
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA) (“Aura” or the “Company”), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for [...]
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Chris [...]
LifeStance to Present at Upcoming Investor Conferences
01/09/2026
SCOTTSDALE, Ariz., Sept. 01, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced that management will present at [...]
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
01/09/2026
SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
Haypp Group to Participate in Key Global Tobacco and Nicotine Conferences This Fall
01/09/2026
Washington, D.C, USA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Haypp Group , parent company of U.S. online nicotine pouch retailers Nicokick.com and Northerner.com , today announced that its leadership will participate in [...]
Research Team Wins Heinz Maurer Award for Linking Bacterium to Eczema Barrier Failure
01/09/2026
Using Lipotype's lipidomics platform, scientists map how Staphylococcus hominis affects the skin's lipid environment in atopic dermatitis, opening promising pathways for eczema treatment DRESDEN, Germany, Sept. 01, 2026 [...]
Attelia Expands the International Patient Experience with New Health Tour Mobile App
01/09/2026
The personalised platform brings treatment planning, online consultations, appointments, transfers, real-time support and long-term aftercare into one secure digital journey ANTALYA, Turkiye, Sept. 01, 2026 (GLOBE [...]

Pages